UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062670
Receipt number R000071628
Scientific Title A prospective observational study of rehabilitation and functional outcomes in patients with disorders of consciousness
Date of disclosure of the study information 2026/09/01
Last modified on 2026/08/24 16:52:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study of rehabilitation and functional outcomes in patients with disorders of consciousness

Acronym

A prospective observational study of rehabilitation and functional outcomes in patients with disorders of consciousness

Scientific Title

A prospective observational study of rehabilitation and functional outcomes in patients with disorders of consciousness

Scientific Title:Acronym

A prospective observational study of rehabilitation and functional outcomes in patients with disorders of consciousness

Region

Japan


Condition

Condition

Patients with brain injuries such as stroke, head trauma, hypoxic encephalopathy and encephalitis

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate the association between the severity of impaired consciousness at admission, changes in consciousness over time, and functional outcomes in patients with brain injury who presented with impaired consciousness and underwent inpatient rehabilitation at the Rehabilitation Ward of Fujita Health University Hospital. In addition, we will examine the associations between functional outcomes and other clinical factors and assess their relative contributions to these outcomes.

Basic objectives2

Others

Basic objectives -Others

To investigate the associations of the severity and longitudinal changes of disorders of consciousness with functional outcomes.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Functional Independence Measure score at discharge

Key secondary outcomes

The following outcome measures will be collected: total Functional Independence Measure (FIM) score and individual FIM subscale scores at admission; individual FIM subscale scores at discharge; total Coma Recovery Scale-Revised (CRS-R) score and individual CRS-R subscale scores at admission and discharge; FIM gain; FIM efficiency; length of hospital stay; discharge destination; and amount of rehabilitation provided.
Basic demographic and clinical information will also be collected, including age, sex, diagnosis, date of injury or disease onset, dates of admission and discharge, and treatment history. In addition, routinely collected assessment data on functional impairments and activity limitations obtained by the Department of Rehabilitation and the Rehabilitation Division will be included. Results of blood tests, imaging studies, and other examinations performed as part of routine clinical care will also be collected as necessary to determine disease severity, complications, general medical status, and clinical course.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients admitted to the Rehabilitation Ward of Fujita Health University Hospital.
2. Patients aged 18 years or older with brain injury, including stroke, traumatic brain injury, hypoxic encephalopathy, or encephalitis, who were admitted to the Rehabilitation Ward of Fujita Health University Hospital within 3 months of injury or disease onset.
3. Patients assessed by the attending physician as having impaired consciousness.
4. Patients who provided written informed consent to participate in the study after receiving a full explanation of the study and demonstrating adequate understanding, either personally or through a legal representative.
5. Patients able to undergo routine clinical assessments in Japanese.

Key exclusion criteria

1. Patients who themselves, or whose legal representatives, have requested withdrawal of consent to participate in the study.
2. Patients whose impaired consciousness is considered to be primarily attributable to systemic conditions, including metabolic, endocrine, respiratory, infectious, or other systemic causes.
3. Patients with a pre-existing central nervous system disorder, such as stroke, traumatic brain injury, hypoxic encephalopathy, or encephalitis, that occurred before the onset of the brain injury responsible for the current hospitalization, and whose level of consciousness is considered difficult to assess because of the effects of the pre-existing condition, as determined by the attending physician or principal investigator.
4. Patients deemed unsuitable for participation in this study by the attending physician or principal investigator.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University

Division name

Department of Rehabilitation Medicine School of Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

TEL

0562-93-2167

Email

yosh1201@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Yoshitaka
Middle name
Last name Wada

Organization

Fujita Health University

Division name

Department of Rehabilitation Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

TEL

0562-93-2167

Homepage URL


Email

yosh1201@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Fujita Health University

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 07 Month 01 Day

Date of IRB

2026 Year 08 Month 07 Day

Anticipated trial start date

2026 Year 09 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a prospective observational study.


Management information

Registered date

2026 Year 08 Month 24 Day

Last modified on

2026 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071628